SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: TDP-43 Splicing Modulation Therapy

idea 1,266 words KG: Biomarker 2026-03-22

kind:idea kind:therapy-idea section:ideas state:published

Contents

TDP-43 Splicing Modulation Therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Cryptic Exon Silencing Restoration
Score: 0.46 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 PARP1 Inhibition Therapy
Score: 0.58 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 RNA Granule Nucleation Site Modulation
Score: 0.48 Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 Cross-Seeding Prevention Strategy
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44 Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived What determines the specificity of TDP-43-induced mitochondr
neurodegeneration · failed How does chronic cGAS/STING activation downstream of TDP-43
neuroinflammation · failed What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed

What upstream mechanisms cause TDP-43 to trigger mPTP openin
neurodegeneration · failed What mechanisms underlie TDP-43's contribution to cognitive
neurodegeneration · failed What determines the selectivity and efficiency of intercellu
neurodegeneration · completed What are the specific design principles for small molecules
medicinal chemistry · failed Does DNAJB6 directly inhibit cross-seeding between tau, α-sy
neurodegeneration · failed What is the therapeutic window between insufficient and toxi
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed

Related Experiments (25)

cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95 TDP-43 mutant mouse model cGAS/STING pathway analysis
validation · proposed · Score: 0.90 TDP-43 mitochondrial invasion and DNA release via mPTP
exploratory · proposed · Score: 0.90 TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90 cGAS/STING pathway validation in TDP-43 mutant mice
validation · proposed · Score: 0.85

TDP-43 pathology prevalence and distribution in AD cases
exploratory · proposed · Score: 0.80 APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75 Cognitive impact of TDP-43 pathology in AD patients
clinical · proposed · Score: 0.70 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40 Prion Strain Diversity and Selective Vulnerability in CJD
clinical · proposed · Score: 0.40 Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40 Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40 Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40

Knowledge Graph (11 edges)

Biomarker biomarker_for Thyroid Cancer

Biomarker correlates_with Disease Trajectory

Biomarker biomarker_for Septic Shock

Biomarker involved_in Sepsis Diagnosis

Biomarker biomarker_for Prostate Cancer

Biomarker biomarker_for Aging

Biomarker biomarker_for Amyotrophic Lateral Sclerosis

Biomarker biomarker_for Frontotemporal Dementia

Biomarker biomarker_for Alzheimer's Disease

HMGB1 biomarker_for Biomarker

SciDEX — scidex.ai — Dashboard | Atlas